ADHD - Combined Type Clinical Trial
— MINADHDOfficial title:
A Self-guided Internet-delivered Intervention for Adults With ADHD: Study Protocol for a Micro-randomized Trial Investigating the Use of Reminders
NCT number | NCT04511169 |
Other study ID # | 90483 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 20, 2020 |
Est. completion date | March 1, 2021 |
Verified date | May 2020 |
Source | Haukeland University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity/impulsivity that are persistent across situations and time. ADHD in adulthood, with an estimated prevalence of 2 - 3 %, is associated with challenges that may have severe consequences on their daily life functioning. Still, the availability of evidence-based psychological interventions is limited. Interventions delivered over the Internet is promising, because it may increase the availability of effective psychological interventions for a larger group of adults with ADHD. However, studies show that lack of sustained adherence is a challenge in self-guided internet interventions. Digital reminders may help increase adherence and engagement in these interventions.
Status | Completed |
Enrollment | 100 |
Est. completion date | March 1, 2021 |
Est. primary completion date | February 20, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults with a diagnosis of ADHD - Access to a computer, smartphone and the Internet. - Speaks, writes and read Norwegian Exclusion Criteria: - Current self-reported diagnosis of severe psychiatric illness (ongoing substance abuse, suicidal ideation or psychosis). - Ongoing psychological treatment for ADHD or other psychiatric illnesses. |
Country | Name | City | State |
---|---|---|---|
Norway | Community Sample | Bergen |
Lead Sponsor | Collaborator |
---|---|
Haukeland University Hospital | University of Bergen |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | number of remainders | number of remainders | up to 8 weeks | |
Secondary | The Adult ADHD Self-Rating Scale | includes all the 18 symptoms of ADHD included in the diagnostic manual (DSM-5). ASRS is a self-report scale with 18 items, and is divided into two subscales; one scale measuring problems with Inattention (9 questions), and one scale measuring problems with Hyperactivity (9 questions). 0 to 16 means unlikely to have ADHD, 17 to 23 means likely to have ADHD, and 24 to 36 means highly likely to have ADHD | up to 40 weeks | |
Secondary | Adult ADHD Quality of Life Measure | Each item is rated by participant s on a five-point Likert scale ranging from "Not at all/ Never" (1) to "Extremely/Very Often" (5). | up to 40 weeks | |
Secondary | The perceived stress scale | The Perceived Stress Scale (PSS) is a widely used psychological instrument for measuring stress. Items were designed to measure stress and how uncontrollable respondents find their lives during the last month (Cohen et al, 1983). The PSS version used in this study has 10 items with response alternatives 0 (never) to 4 (very often) and an internal reliability of a Cronbach's alpha of 0.89 (Roberti et al, 2006) | up to 40 weeks | |
Secondary | The Patient Health Questionnaire-9 | The Patient Health Questionnaire-9 (PHQ-9: Kroenke et al., 2001) is a self-report tool used to assess the presence and severity of depressive symptoms. Reliability and validity of the tool have indicated it has sound psychometric properties. Internal consistency of the PHQ-9 has been shown to be high | up to 40 weeks | |
Secondary | The self-compassion scale - short form | The scale includes 6 subscales that measure how often people respond to feelings of inadequacy or suffering with self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification. Questions are rated on a scale from 1 (almost never) to 5 (almost always). | up to 40 weeks | |
Secondary | The Perceived Deficits Questionnaire 5-item | brief assessment of subjective cognitive difficulties and covers problems with concentration (e.g. "trouble concentrating on things like watching a television program or reading a book?"), memory (e.g. "forget what you talked about after a telephone conversation?"), and executive functioning (e.g. "have trouble getting things organized?"). Every item is rated on a scale of 0 (Never) to 4 (Almost always) to yield a sum score of 0 to 20, with higher scores indicating greater severity of cognitive symptoms. | up to 40 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06465641 -
Methylphenidate in KBG Syndrome: N-of-1 Series
|
Phase 4 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT04799886 -
Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.
|
||
Completed |
NCT05452954 -
Psychosocial ADHD Interventions - Brief Parent Training
|
N/A | |
Recruiting |
NCT03313349 -
A School-Based Intervention to Improve Social Functioning
|
N/A | |
Completed |
NCT01727414 -
Attention Deficit Disorder Medication Response Study
|
Phase 4 | |
Active, not recruiting |
NCT05930912 -
Psychiatric Orders in Psychoanalytic Treatment of ASD
|
||
Recruiting |
NCT05924594 -
Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301
|
Phase 3 | |
Recruiting |
NCT04781972 -
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
|
Phase 4 | |
Active, not recruiting |
NCT05286762 -
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
|
Phase 3 | |
Not yet recruiting |
NCT06235177 -
Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues
|
Early Phase 1 | |
Recruiting |
NCT04504890 -
Ocular-vestibular Biomarker Identification for ADHD
|
||
Recruiting |
NCT06299189 -
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
|
N/A | |
Recruiting |
NCT04729439 -
Technology-Enhanced Executive Functioning Intervention for ADHD
|
Phase 1 | |
Completed |
NCT03335748 -
the Cogmed Program for Youths With ADHD
|
N/A | |
Completed |
NCT05631626 -
Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
|
Phase 3 |